Genesis Ventures enables talent to create successful technology startups while aiming to make Greece a unicorn producer and a regional technology hub.

Genesis Ventures

Genesis Ventures is an angel co-investment fund providing pre-seed/seed capital & hands-on support to early-stage founders in Greece & SE Europe. #genesis #greece #tech

DayOne is 🔙 in Athens! I'm delighted to announce that applications for the next DayOne (DO), DO #6, are now open! 🎉

As a reminder, DayOne is a 6-week founder program run by Genesis Ventures  for startups that want to get their first institutional investment and scale globally.

What awaits the DayOne founders?
💸The chance to receive our €150,000 ticket
🚀6 weeks of top-rated workshops, exclusive meet-up sessions with exited founders and fellow VCs, and 1-on-1 time with our GPs Stergios Anastasiadis and Dimitris M.
🇬🇷1 intensive in-person week in Athens, Greece, followed by 5 weeks of online sessions

Why DayOne?
🤝Proven success with 5 closed investments
☄️3 positive investment decisions out of our latest cohort (DO #5)!

For teams travelling to Athens for the program, we’re covering €500 worth of expenses.

🗓Link to apply in the first comment! Apply by September 15th to be considered for the program. Applications are rolling, so apply as soon as possible to secure your spot. 

Join us in crafting the future! 🦄
Lefteris Papadopoulos Filippos Tamvakakis Marina Kalogerakou

📣 Attention, Genesis Ventures friends and fam! Exciting news alert! 📣 

We're thrilled to announce the launch of our brand-new company blog on Medium! Get ready for insider information on the assessment of early-stage VC deals 🚀, informative pieces on disruptive tech 🤖, and insightful stories from our founders and team 💡. Visit our blog using the link below for a taste of what we have learned from working in early-stage investing 🌱. And don't forget to hit that follow button for updates!

Stergios Anastasiadis Dimitris M. Marina Kalogerakou Lefteris Papadopoulos Filippos Tamvakakis

Super excited to share with you Genesis Ventures' first Founder Matchmaking event in collaboration with ODYCEO, the entrepreneurship society of National Technical University of Athens! 🚀

Our "Founders' Dating" event is all about connecting aspiring entrepreneurs from day zero, helping them form high-quality teams with unique missions. 🤝

During the event, aspiring founders will introduce themselves, share their skills and backgrounds, and connect with individuals whose abilities complement their own. Dimitris M. will also lead his workshop, "Building the Right Founding Team." 🛠️

If you're thinking about starting a company, looking for a co-founder, or if your team is looking to make new founding hires, this event is just right for you!

Date: Tuesday, 21st May 2024
Time: 17:30 - 21:30

Express your interest using the form in the first comment.

See you there! 🎉

Stergios Anastasiadis Filippos Tamvakakis Marina Kalogerakou

Exciting News: The Genesis team is coming to London! 🏴󠁧󠁢󠁥󠁮󠁧󠁿💂‍♀️

Join us for the "Greeking Out in London" event, co-hosted by Genesis Ventures and Endeavor Greece, on May 15th! Uncover the dynamic evolution of the Greek startup ecosystem, as revealed by our distinguished panellists of founders and investors. The evening will be concluded with networking over drinks and nibbles. 🍻 

📅 Date: May 15th 
📍 Location: The Hellenic Centre, London, W1
⏰ Time: 18:00

We will explore topics vital for startuppers. For instance, Genesis' portfolio founders Carolina Bell, Alexander Xydas, and Ioannis Kasinopoulos will give you tips on securing your first customers. More exciting speaker updates are on the way — stay tuned! 🔥 
 
Spaces are limited — so lock your spot early! 🔒 Registration link in comments. 

Looking forward to seeing you all in London! 🚀


Marina Kalogerakou Stergios Anastasiadis Dimitris M. Lefteris Papadopoulos Thanasi Tsiodras

Excited to announce our #investment in the pre-seed round of Averywell 🚀 , which helps diagnose early lung #cancer in asymptomatic patients with a simple blood test 🩸. Lung cancer ranks as the third most prevalent cancer globally, claiming the top spot in cancer-related fatalities ☠ . #MicroRNA #technology is making its way into commercialisation and while some startups use microRNA for various cancers, none have so far shown the impressive accuracy of Averywell in reducing false positives for lung cancer. The data has been tested in a small but significant number of patients and will be validated in a larger cohort with this round of #funding by Genesis Ventures and several strategic angel investors. Cherry NY CHIA, a formidable technical founder whom I had worked with in my old days in #Singapore, is the right person to take this forward. 
Feel free to check Thanasi Tsiodras's article in the first comment for more on why we invested. 
Stergios Anastasiadis Marina Kalogerakou Filippos Tamvakakis Lefteris Papadopoulos

11 teams, 24 founders, 1 pitching session, 6 training sessions, 2 meet the founder sessions, 2 office hour sessions for each team, 1 mini hackathon, and a happy hour...made up the 1st week of DayOne cohort #5 in Patra last week 👊🏼 The best cohort to date 👊🏼🚀🇬🇷 Cohort #6 is just around the corner!

In the next 5 weeks: 2 more pitching sessions, 5 training sessions, 2 meet the founder sessions, and more office hours 🚀 and maybe, just maybe a few investments as well 😱

Want to 🙏🏽  Yiannis Kanellopoulos & Maria Venetsanou at code4thought for giving us their space plus George Sidiropoulos and Elias Kokkinis that provided wonderful insights from their founder journey ❤️

Lefteris Papadopoulos Filippos Tamvakakis Dimitris M. Marina Kalogerakou
#dayone #genesisventures #greekstartups

Metric
Company Name	Genesis Ventures
Symbol
MSH ID	VC:GENESIS-VENTURES
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	GR
Stage
Employee Count	8
Website	genesis-ventures.vc
LinkedIn	genesisvc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

GENE

VC:GENESIS-VENTURES

Genesis Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue